List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Subcutaneous Biologics Market Size Analysis from 2023 to 2028
1.5.1 Global Subcutaneous Biologics Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Subcutaneous Biologics Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Subcutaneous Biologics Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Subcutaneous Biologics Industry Impact
Chapter 2 Global Subcutaneous Biologics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Subcutaneous Biologics (Volume and Value) by Type
2.1.1 Global Subcutaneous Biologics Consumption and Market Share by Type (2017-2022)
2.1.2 Global Subcutaneous Biologics Revenue and Market Share by Type (2017-2022)
2.2 Global Subcutaneous Biologics (Volume and Value) by Application
2.2.1 Global Subcutaneous Biologics Consumption and Market Share by Application (2017-2022)
2.2.2 Global Subcutaneous Biologics Revenue and Market Share by Application (2017-2022)
2.3 Global Subcutaneous Biologics (Volume and Value) by Regions
2.3.1 Global Subcutaneous Biologics Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Subcutaneous Biologics Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Subcutaneous Biologics Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Subcutaneous Biologics Consumption by Regions (2017-2022)
4.2 North America Subcutaneous Biologics Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Subcutaneous Biologics Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Subcutaneous Biologics Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Subcutaneous Biologics Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Subcutaneous Biologics Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Subcutaneous Biologics Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Subcutaneous Biologics Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Subcutaneous Biologics Sales, Consumption, Export, Import (2017-2022)
4.10 South America Subcutaneous Biologics Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Subcutaneous Biologics Market Analysis
5.1 North America Subcutaneous Biologics Consumption and Value Analysis
5.1.1 North America Subcutaneous Biologics Market Under COVID-19
5.2 North America Subcutaneous Biologics Consumption Volume by Types
5.3 North America Subcutaneous Biologics Consumption Structure by Application
5.4 North America Subcutaneous Biologics Consumption by Top Countries
5.4.1 United States Subcutaneous Biologics Consumption Volume from 2017 to 2022
5.4.2 Canada Subcutaneous Biologics Consumption Volume from 2017 to 2022
5.4.3 Mexico Subcutaneous Biologics Consumption Volume from 2017 to 2022
Chapter 6 East Asia Subcutaneous Biologics Market Analysis
6.1 East Asia Subcutaneous Biologics Consumption and Value Analysis
6.1.1 East Asia Subcutaneous Biologics Market Under COVID-19
6.2 East Asia Subcutaneous Biologics Consumption Volume by Types
6.3 East Asia Subcutaneous Biologics Consumption Structure by Application
6.4 East Asia Subcutaneous Biologics Consumption by Top Countries
6.4.1 China Subcutaneous Biologics Consumption Volume from 2017 to 2022
6.4.2 Japan Subcutaneous Biologics Consumption Volume from 2017 to 2022
6.4.3 South Korea Subcutaneous Biologics Consumption Volume from 2017 to 2022
Chapter 7 Europe Subcutaneous Biologics Market Analysis
7.1 Europe Subcutaneous Biologics Consumption and Value Analysis
7.1.1 Europe Subcutaneous Biologics Market Under COVID-19
7.2 Europe Subcutaneous Biologics Consumption Volume by Types
7.3 Europe Subcutaneous Biologics Consumption Structure by Application
7.4 Europe Subcutaneous Biologics Consumption by Top Countries
7.4.1 Germany Subcutaneous Biologics Consumption Volume from 2017 to 2022
7.4.2 UK Subcutaneous Biologics Consumption Volume from 2017 to 2022
7.4.3 France Subcutaneous Biologics Consumption Volume from 2017 to 2022
7.4.4 Italy Subcutaneous Biologics Consumption Volume from 2017 to 2022
7.4.5 Russia Subcutaneous Biologics Consumption Volume from 2017 to 2022
7.4.6 Spain Subcutaneous Biologics Consumption Volume from 2017 to 2022
7.4.7 Netherlands Subcutaneous Biologics Consumption Volume from 2017 to 2022
7.4.8 Switzerland Subcutaneous Biologics Consumption Volume from 2017 to 2022
7.4.9 Poland Subcutaneous Biologics Consumption Volume from 2017 to 2022
Chapter 8 South Asia Subcutaneous Biologics Market Analysis
8.1 South Asia Subcutaneous Biologics Consumption and Value Analysis
8.1.1 South Asia Subcutaneous Biologics Market Under COVID-19
8.2 South Asia Subcutaneous Biologics Consumption Volume by Types
8.3 South Asia Subcutaneous Biologics Consumption Structure by Application
8.4 South Asia Subcutaneous Biologics Consumption by Top Countries
8.4.1 India Subcutaneous Biologics Consumption Volume from 2017 to 2022
8.4.2 Pakistan Subcutaneous Biologics Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Subcutaneous Biologics Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Subcutaneous Biologics Market Analysis
9.1 Southeast Asia Subcutaneous Biologics Consumption and Value Analysis
9.1.1 Southeast Asia Subcutaneous Biologics Market Under COVID-19
9.2 Southeast Asia Subcutaneous Biologics Consumption Volume by Types
9.3 Southeast Asia Subcutaneous Biologics Consumption Structure by Application
9.4 Southeast Asia Subcutaneous Biologics Consumption by Top Countries
9.4.1 Indonesia Subcutaneous Biologics Consumption Volume from 2017 to 2022
9.4.2 Thailand Subcutaneous Biologics Consumption Volume from 2017 to 2022
9.4.3 Singapore Subcutaneous Biologics Consumption Volume from 2017 to 2022
9.4.4 Malaysia Subcutaneous Biologics Consumption Volume from 2017 to 2022
9.4.5 Philippines Subcutaneous Biologics Consumption Volume from 2017 to 2022
9.4.6 Vietnam Subcutaneous Biologics Consumption Volume from 2017 to 2022
9.4.7 Myanmar Subcutaneous Biologics Consumption Volume from 2017 to 2022
Chapter 10 Middle East Subcutaneous Biologics Market Analysis
10.1 Middle East Subcutaneous Biologics Consumption and Value Analysis
10.1.1 Middle East Subcutaneous Biologics Market Under COVID-19
10.2 Middle East Subcutaneous Biologics Consumption Volume by Types
10.3 Middle East Subcutaneous Biologics Consumption Structure by Application
10.4 Middle East Subcutaneous Biologics Consumption by Top Countries
10.4.1 Turkey Subcutaneous Biologics Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Subcutaneous Biologics Consumption Volume from 2017 to 2022
10.4.3 Iran Subcutaneous Biologics Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Subcutaneous Biologics Consumption Volume from 2017 to 2022
10.4.5 Israel Subcutaneous Biologics Consumption Volume from 2017 to 2022
10.4.6 Iraq Subcutaneous Biologics Consumption Volume from 2017 to 2022
10.4.7 Qatar Subcutaneous Biologics Consumption Volume from 2017 to 2022
10.4.8 Kuwait Subcutaneous Biologics Consumption Volume from 2017 to 2022
10.4.9 Oman Subcutaneous Biologics Consumption Volume from 2017 to 2022
Chapter 11 Africa Subcutaneous Biologics Market Analysis
11.1 Africa Subcutaneous Biologics Consumption and Value Analysis
11.1.1 Africa Subcutaneous Biologics Market Under COVID-19
11.2 Africa Subcutaneous Biologics Consumption Volume by Types
11.3 Africa Subcutaneous Biologics Consumption Structure by Application
11.4 Africa Subcutaneous Biologics Consumption by Top Countries
11.4.1 Nigeria Subcutaneous Biologics Consumption Volume from 2017 to 2022
11.4.2 South Africa Subcutaneous Biologics Consumption Volume from 2017 to 2022
11.4.3 Egypt Subcutaneous Biologics Consumption Volume from 2017 to 2022
11.4.4 Algeria Subcutaneous Biologics Consumption Volume from 2017 to 2022
11.4.5 Morocco Subcutaneous Biologics Consumption Volume from 2017 to 2022
Chapter 12 Oceania Subcutaneous Biologics Market Analysis
12.1 Oceania Subcutaneous Biologics Consumption and Value Analysis
12.2 Oceania Subcutaneous Biologics Consumption Volume by Types
12.3 Oceania Subcutaneous Biologics Consumption Structure by Application
12.4 Oceania Subcutaneous Biologics Consumption by Top Countries
12.4.1 Australia Subcutaneous Biologics Consumption Volume from 2017 to 2022
12.4.2 New Zealand Subcutaneous Biologics Consumption Volume from 2017 to 2022
Chapter 13 South America Subcutaneous Biologics Market Analysis
13.1 South America Subcutaneous Biologics Consumption and Value Analysis
13.1.1 South America Subcutaneous Biologics Market Under COVID-19
13.2 South America Subcutaneous Biologics Consumption Volume by Types
13.3 South America Subcutaneous Biologics Consumption Structure by Application
13.4 South America Subcutaneous Biologics Consumption Volume by Major Countries
13.4.1 Brazil Subcutaneous Biologics Consumption Volume from 2017 to 2022
13.4.2 Argentina Subcutaneous Biologics Consumption Volume from 2017 to 2022
13.4.3 Columbia Subcutaneous Biologics Consumption Volume from 2017 to 2022
13.4.4 Chile Subcutaneous Biologics Consumption Volume from 2017 to 2022
13.4.5 Venezuela Subcutaneous Biologics Consumption Volume from 2017 to 2022
13.4.6 Peru Subcutaneous Biologics Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Subcutaneous Biologics Consumption Volume from 2017 to 2022
13.4.8 Ecuador Subcutaneous Biologics Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Subcutaneous Biologics Business
14.1 Abbott Laboratories
14.1.1 Abbott Laboratories Company Profile
14.1.2 Abbott Laboratories Subcutaneous Biologics Product Specification
14.1.3 Abbott Laboratories Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Pfizer Inc.
14.2.1 Pfizer Inc. Company Profile
14.2.2 Pfizer Inc. Subcutaneous Biologics Product Specification
14.2.3 Pfizer Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Genentech Inc.
14.3.1 Genentech Inc. Company Profile
14.3.2 Genentech Inc. Subcutaneous Biologics Product Specification
14.3.3 Genentech Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Novartis AG
14.4.1 Novartis AG Company Profile
14.4.2 Novartis AG Subcutaneous Biologics Product Specification
14.4.3 Novartis AG Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Biogen Idec
14.5.1 Biogen Idec Company Profile
14.5.2 Biogen Idec Subcutaneous Biologics Product Specification
14.5.3 Biogen Idec Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 AbbVie Inc.
14.6.1 AbbVie Inc. Company Profile
14.6.2 AbbVie Inc. Subcutaneous Biologics Product Specification
14.6.3 AbbVie Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 F. Hoffmann-La Roche AG
14.7.1 F. Hoffmann-La Roche AG Company Profile
14.7.2 F. Hoffmann-La Roche AG Subcutaneous Biologics Product Specification
14.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Bristol-Myers Squibb
14.8.1 Bristol-Myers Squibb Company Profile
14.8.2 Bristol-Myers Squibb Subcutaneous Biologics Product Specification
14.8.3 Bristol-Myers Squibb Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Eisai Inc.
14.9.1 Eisai Inc. Company Profile
14.9.2 Eisai Inc. Subcutaneous Biologics Product Specification
14.9.3 Eisai Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Takeda Pharmaceuticals Ltd.
14.10.1 Takeda Pharmaceuticals Ltd. Company Profile
14.10.2 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product Specification
14.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Alnylam Pharmaceuticals
14.11.1 Alnylam Pharmaceuticals Company Profile
14.11.2 Alnylam Pharmaceuticals Subcutaneous Biologics Product Specification
14.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Bayer AG
14.12.1 Bayer AG Company Profile
14.12.2 Bayer AG Subcutaneous Biologics Product Specification
14.12.3 Bayer AG Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 GlaxoSmithKline
14.13.1 GlaxoSmithKline Company Profile
14.13.2 GlaxoSmithKline Subcutaneous Biologics Product Specification
14.13.3 GlaxoSmithKline Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Subcutaneous Biologics Market Forecast (2023-2028)
15.1 Global Subcutaneous Biologics Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Subcutaneous Biologics Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Subcutaneous Biologics Value and Growth Rate Forecast (2023-2028)
15.2 Global Subcutaneous Biologics Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Subcutaneous Biologics Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Subcutaneous Biologics Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Subcutaneous Biologics Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Subcutaneous Biologics Consumption Forecast by Type (2023-2028)
15.3.2 Global Subcutaneous Biologics Revenue Forecast by Type (2023-2028)
15.3.3 Global Subcutaneous Biologics Price Forecast by Type (2023-2028)
15.4 Global Subcutaneous Biologics Consumption Volume Forecast by Application (2023-2028)
15.5 Subcutaneous Biologics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
